期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
经腋窝入路无充气腔镜下手术对早期甲状腺肿瘤患者免疫功能及美容效果的影响 被引量:7
1
作者 黄卫荣 陈晓东 李恩惠 《中国内镜杂志》 2023年第2期35-40,共6页
目的探讨经腋窝入路无充气腔镜下手术对早期甲状腺肿瘤患者免疫功能及美容效果的影响。方法选取2019年5月-2021年6月该院收治的98例早期甲状腺肿瘤患者为研究对象,随机分为观察组和对照组,观察组(n=49)给予经腋窝入路无充气腔镜手术,对... 目的探讨经腋窝入路无充气腔镜下手术对早期甲状腺肿瘤患者免疫功能及美容效果的影响。方法选取2019年5月-2021年6月该院收治的98例早期甲状腺肿瘤患者为研究对象,随机分为观察组和对照组,观察组(n=49)给予经腋窝入路无充气腔镜手术,对照组(n=49)给予开放性甲状腺肿瘤切除术。对比两组患者手术相关指标、淋巴结清除效果、免疫功能、并发症发生率及术后3个月美容效果。结果观察组术中出血量为(12.27±4.53)mL,术后引流量为(78.25±19.36)mL,明显少于对照组的(23.71±6.86)和(136.24±45.28)mL(均P<0.05)。观察组手术时间为(110.16±11.57)min,明显长于对照组的(61.34±6.27)min(P<0.05)。观察组淋巴结清扫数目为(2.02±1.03)枚,与对照组的(1.98±1.05)枚比较,差异无统计学意义(P>0.05)。术后1周,观察组CD3+为(56.84±5.06)%,CD4^(+)为(33.72±4.08)%,明显高于对照组的(50.26±4.87)%和(28.15±3.97)%(均P<0.05),而观察组CD8^(+)为(35.14±5.32)%,明显低于对照组的(38.29±5.76)%(P<0.05)。观察组并发症发生率为0.00%,明显低于对照组的8.16%,但差异无统计学意义(P>0.05)。观察组美容满意度为97.96%,明显高于对照组的81.63%(P<0.05)。结论经腋窝入路无充气腔镜下手术治疗早期甲状腺肿瘤患者,能改善手术指标和免疫功能,降低并发症发生率,并提高美容满意度。 展开更多
关键词 早期甲状腺肿瘤 无充气腔镜下 经腋窝入路 免疫功能 美容效果
下载PDF
Optical monitoring and intra-day variabilities of BL Lac Objects OJ 287 被引量:1
2
作者 Yu-Hai Yuan Jun-Hui Fan +4 位作者 Hong Wu Jing-Meng Hao wei-rong huang Xiao-Lan Liu Hong-Ren huang 《Research in Astronomy and Astrophysics》 SCIE CAS CSCD 2021年第6期263-275,共13页
Using the 1.26 m National Astronomical Observatory-Guangzhou University Infrared/Optical Telescope(NGT),we monitor one BL Lac object,OJ 287.For this source,we obtain 15094 gri observations(4900 at g band,5184 at r ban... Using the 1.26 m National Astronomical Observatory-Guangzhou University Infrared/Optical Telescope(NGT),we monitor one BL Lac object,OJ 287.For this source,we obtain 15094 gri observations(4900 at g band,5184 at r band and 5010 at i band)in 155 nights from 2014 December 13 to 2019 March15.Based on the upper observations,we obtain the following results.(1)The total variation amplitude is~2.3 mag.(2)There are intra-day variabilities(IDVs).The IDV timescales(△T)are in the range from 7.69 min(Δm=0.06±0.02 mag)to 371.09 min(Δm=0.26±0.04 mag).(3)There are strong correlations betweenΔT andΔm,△m=(2.91±0.66)×10^(-4)ΔT+(0.08±0.009),with r=0.52,p=5.33×10^(-5).(4)There are intra-day periods in this source,with the period P≈94 min on 2017 December 10.When we supplement the observations from the literature,we can obtain that the long-term period is about 12.02±0.41 yr.(5)The spectral properties of OJ 287 show the bluer-when-brighter behavior,whatever state the source is at. 展开更多
关键词 quasars:individual(OJ 287) PHOTOMETRY
下载PDF
KRT17 Promotes the Activation of HSCs via EMT in Liver Fibrosis 被引量:1
3
作者 Jing Chen Si-Jia Ge +5 位作者 Hai-Juan Feng Shu-Zhen Wu Ran Ji wei-rong huang Wei huang Cui-Hua Lu 《Journal of Clinical and Translational Hepatology》 SCIE 2022年第2期207-218,共12页
Background and Aims:Although activation of hepatic stellate cells(HSCs)plays a central role in the development of liver fibrosis,the mechanism underlying the activation of HSCs remains unclear.Keratin 17(KRT17),a memb... Background and Aims:Although activation of hepatic stellate cells(HSCs)plays a central role in the development of liver fibrosis,the mechanism underlying the activation of HSCs remains unclear.Keratin 17(KRT17),a member of the intermediate filament family,can regulate tumor cell proliferation and migration.The current study aimed to elucidate the role of KRT17 in the activation of HSCs and the mechanisms underlying liver fibrosis.Methods:The expression of KRT17 was determined using immunohistochemistry in tissue microarray.Western blotting and qRT-PCR assays were used to determine the KRT17 expression in fibrotic liver tissues obtained from human subjects and mice.LX-2 cells were treated with TGF-β1 recombinant protein and adipocyte differentiation mixture(MDI)mix to induce and reverse LX-2 cell activation,respectively,in order to explore the correlation between KRT17 and HSC activation.Additionally,cell proliferation and migration abilities of LX-2 cells transfected with KRT17-overexpressing plasmid or small interfering RNA were determined using CCK-8,flow cytometry,Transwell,and wound healing assays.Finally,rescue assay was used to explore the role of KRT17 in HSC activation and epithelial-mesenchymal transition(EMT).Results:The expression of KRT17 was higher in the hu-man and mouse fibrotic liver tissues than in healthy liver tissues,and it was positively correlated with HSC activa-tion.Upregulated KRT17 enhanced proliferation,migration,HSC activation and EMT in LX-2 cells,while knockdown of KRT17 reversed these effects.TGF-β1 recombinant protein accelerated KRT17-mediated EMT,HSC activation and proliferation,while TGF-β1 inhibitor counteracted the effect of KRT17 in vitro.Conclusions:KRT17 promoted HSC activation,proliferation and EMT in hepatic fibrosis probably via TGF-β1 signaling,and KRT17 might serve as a therapeutic target for the treatment of liver fibrosis. 展开更多
关键词 KRT17 Hepatic stellate cell activation Liver fibrosis Epithelial-mesenchymal transition TGF-βsignaling.
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部